Mycophenolate Mofetil D4

Mycophenolate Mofetil D4 is a deuterated derivative of Mycophenolate Mofetil, which is an immunosuppressive medication used to prevent organ rejection in patients who have received a kidney, liver, or heart transplant. Mycophenolate Mofetil D4 is used for research purposes, particularly in the field of pharmacokinetics, to determine the absorption, distribution, metabolism, and excretion of Mycophenolate Mofetil in the body. The chemical formula for Mycophenolate Mofetil D4 is C23H18D4NO6, and its molecular weight is 462.54 g/mol. It is a prodrug that is rapidly hydrolyzed in the body to its active form, Mycophenolic acid (MPA). MPA works by inhibiting the activity of inosine monophosphate dehydrogenase (IMPDH), which is required for the synthesis of guanosine nucleotides. This inhibition leads to a decrease in the proliferation of T and B lymphocytes, which are responsible for the rejection of transplanted organs. Mycophenolate Mofetil D4 is typically administered orally as a tablet or capsule. Its pharmacokinetic properties are similar to those of Mycophenolate Mofetil, but its deuterated structure allows for more accurate measurement of drug levels in biological samples. It is important to note that Mycophenolate Mofetil D4 is not approved for clinical use and should only be used for research purposes under appropriate laboratory conditions.